A detailed history of Hilton Capital Management, LLC transactions in Immutep LTD stock. As of the latest transaction made, Hilton Capital Management, LLC holds 30,675 shares of IMMP stock, worth $57,055. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,675
Holding current value
$57,055
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$1.61 - $1.8 $49,386 - $55,215
30,675 New
30,675 $55,000

Others Institutions Holding IMMP

About IMMUTEP Ltd


  • Ticker IMMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,000
  • Market Cap $161M
  • Description
  • Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...
More about IMMP
Track This Portfolio

Track Hilton Capital Management, LLC Portfolio

Follow Hilton Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hilton Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hilton Capital Management, LLC with notifications on news.